Health Tech Forum - Nov. 2

Description

Game Changer Series:  Medical device startups

Featuring:    Edward Allegra, CEO, BioLum
                       Ron Nag, CEO, BioLert

The Game Changer Series focuses on local healthcare startups in North Texas that are changing the way we view healthcare today.  Find out how BioLum, which is developing a mobile health solution for asthma management, and BioLert, which has developed an app to monitor epileptic seizures, are changing the quality of health care for thousands of patients right here in our own backyard.  Through innovative products and services, companies like these are providing a window into the future.

About the speakers and their companies:

Edward Allegra suffered with asthma as a child and has made it his mission to help other asthmatics achieve a higher quality of life.  He is currently managing the company and developing relationships with investors, partners, and customers.  He graduated from SMU in 2016 with a focus on Economics and Biology.

BioLum Sciences, LLC is the developer of a mobile health device that aids in the diagnosis, monitoring, and treatment of airway inflammation by ultimately enabling patients to measure asthma symptoms in the comfort of their home.  BioLum Sciences has capitalized on the thriving business sector in the Dallas area to forge partnerships and a strong consultant network.






Serving as CEO, Ron Nag leverages deep leadership experience earned during nearly three decades of technology industry roles.  He recently held the position of Executive Director of Texas Instruments' Embedded Processing & Analog High Speed Products division.  He previously served as Business Manager of TI's Mobile Application Processor Business Unit where he was responsible for $835M in revenue yearly while working with major smartphone OEMs.  TI also employed Ron in various domestic and international product and business management roles focused on VoIP, C55x, Emerging End Equipment, Wireless, Industrial and Automotive.  He held similar roles within Cisco Systems as well as optical and Ethernet CPE startups for which he raised $17M.  Prior to sales and management, Ron worked as an embedded developer wireless applications at Motorola and Samsung.  He holds a BSEE from Oakland University and an MBA from Southern Methodist University.

BioLert:  Epilipsy affects nearly 1% of people worldwide (50 million).  Of those individuals, approximately one-third have drug resistant epilepsy (DRE); their seizerues continue despite medication management efforts.  BioLert is a Cloud-based seizure detection and notification software as a service (SaaS) applicaiton for Android smartwatches.  By using off-the-shelf devices of smartwatch and smartphones, BioLert provides a peace of mind to people that are coping with this chronic condition.